7th and 9th Nov - Receptor Regulation Flashcards

1
Q

In which organism was g-protein independent signalling first identified?

A

Slime mould

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How was G-protein independent signalling identified?

A

Mutated Gbeta in slime mould and found that not all GPCR signalling was lost therefore the G protein must not be the sole source of signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline Turki’s 1995 experiment on beta adrenoceptors that showed desensitization.

A

Overdosed non-asthmatics with oxiprenaline over 24h
Collected their airway emipthelial cells and alveolar macrophages
–> Following drug application cAMP response was much lower
–> Forskolin application led to the same AC response in both treated and non-treated therefore reduction in response must be due to Beta adrenoceptor not AC

–> After application the number of beta 2 adrenoceptors decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is homologous desensitisation?

A

Where the attenuation in the signalling response is specific to the receptor being stimulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is heterologous desensitisation?

A

Where collateral receptors signalling are also desensitised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How did Green and Clark (1981) show that desensitisation occurs at the level of the receptor?

A

Used cyc- (lack Beta adrenoceptor) S49 lymphoma cells —> no attenuation
Prepared their membranes and reconstituted with WT lysate containing Galpha S –> attenuation of cAMP levels on long application of agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can you demonstrate that receptor phosphorylation correlates with desensitisation?

A

Label cells with [32-P]-orthophosphate –> 32P-ATP
Lyse cells
Immunoprecipitate receptor
Add agonist –> increase in receptor phosphorylation (shown on autoradiograph)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which residue is a GPCR most commonly phosphorylated on?

A

Serine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which kinase mediated heterologous receptor phosphorylation?

A

PKA/PKC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is heterologous phosphorylation conformation dependent?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is heterologous phosphorylation slow?

A

Yes takes minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What experiment showed that receptor desensitisation was not solely dependent on PKA/PKC?

A

Examined B2 adrenoceptor coupling in S49 lymphoma cells
WT - GPCR –> cAMP –> PKA
Cyc- = Lack GPCR
kin- = Lack PKA, however still showed receptor desensitisation therefore must not be entirely dependent on PKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is BARK?

A

Beta -adrenergic receptor kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who discovered BARK?

A

Benovic 1986

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How was it discovered that there was a missing link between BARK and receptor desensitisation?

A

Purified lung beta adrenoceptors were incubated with kin- S39 lymphoma cell lysate (lack PKA) and [32P]ATP/Mg2+. Expected desensitisation to correlate with receptor phosphorylation and increased [BARK] but it didn’t
Therefore receptor phosphorylation has little to do with desensitisation or something is missing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Who found that Beta-arrestin regulates beta adrenergic receptor function in 1990?

A

Lohse

17
Q

How was arrestin identified as the missing link between BARK and receptor desensitisation?

A

Measured Receptor-gprotein coupling activity against increasing [GRK]. When GRK and Arrestin was present the predicted desensistisation was achieved.

18
Q

Outline the current model of homologous GPCR desensitisation

A

GRK is recruited by the conformation of the receptor
GRK phosphorylates the receptor e.g BARK
Once phosphorylated the GRK recruits arrestin
Arrestin acts as a scaffold for clathrin mediated receptor endocytosis, interacting directly with AP2 and clathrin

19
Q

What are the currently identified GRKs?

A

Visual: Rhodopsin Kinase (GRK1), GRK7 (in cone cells)

Non-Visual: BARK (GRK2), BARK2 (GRK3), GRK4, GRK5 and GRK6

20
Q

What is an RH domain?

A

An RGS homology domain allowing G alpha interaction

21
Q

How are GRK 2/3 recruited to the ligand occupied receptor?

A
  1. GRK2/3 recruitment to activated receptor via Gbeta gamma and PIP2
  2. RGS like domain of GRK2/3 can bind and sequester Galpha subunits
22
Q

Can different arrestins bind the same source GRK?

A

Yes e.g.
ETa receptor - GRK2 –> Arrestin 3
P2Y2 receptor - GRK2 –> Arrestin 2

23
Q

Outline an arrestin signalling complex (not for clathrin mediated endocytosis)

A

Phosphorylation and beta arrestin capped beta adrenoceptor recruits Src to activate MAPK signalling

24
Q

What are the two forms of GPCR signalling?

A

Gprotein dependent –> AC, PLC, PI3K etc.

G protein independent –> MAPK (ERK/JNK), cAMP PDE, DAG Kinases

25
Q

Outline the different signalling pathways that can be elicited using the AT1 receptor

A

Gprotein dependent - Gq –> Vasoconstriction and Fluid Retention

Gprotein independent - Arrestin –> Cardiac contractility and decrease cardiac cell apoptosis

26
Q

What are the clinical benefits of the two forms of AT1 receptor signalling?

A

Currently Hypertension and heart failure is treated w/ ACE inhibitors or angiotensin receptor blockers, however the arrestin AT1 pathway elicits desirable effects in heart failure.

Thus using a biased agonist such as SII-AngII could block undesirable Gq effects and promote desirable Arrestin mediated effects –> greater therapeutic effects than Antagonists

27
Q

What is tachyphylaxis?

A

Decrease in responsiveness of a drug with repeated dosing

28
Q

What is drug tolerance?

A

A higher dose is required with repeated doses to create the desired effects

29
Q

Outline the clinical benefits of using a biased agonist on B2 adrenergic receptors in obstructive lung disease

A

B2 adrenergic receptor regulates airway smooth muscle cell contraction and bronchial tone

Asthma treatment suffers from tachyphylaxis to Beta agonist stimulated bronchodilation, as repeated doses –> increased tolerance –> leads to higher doses –> increased health risks and reduced action of rescue inhalers

Desensitisation is mediated by Beta arrestin 2 sterically preventing g protein association by receptor internalisation thus a biased ligand which only evoked the G protein response would prevent desensitisation